We have previously demonstrated that human cells contain multiple forms of uracil-DNA glycosylase (Caradonna, S. J., Ladner, R., Hansbury, M., Kosciuk, M., Lynch, F., and Muller, S. J. (1996) Exp. Cell Res. 222, 345-359). One of these is an M r 29,000 processed form of the highly conserved uracil-DNA glycosylase (UDG1) located in the mitochondria. The others are located in the nucleus and migrate as a group of at least three distinct bands within the 35,000 -37,000 molecular weight range. In this report, we perform a detailed characterization of the M r 35,000 -37,000 purified proteins. To accomplish this, uracil-DNA glycosylases were affinity purified from HeLa cell nuclear extracts. The proteins were separated by SDS-PAGE, and their identities were verified by renaturation and activity assays. The three protein bands were individually digested with cyanogen bromide, and the resulting peptide fragments were analyzed by direct amino acid sequencing. Peptide sequence, derived from each band, was identical and corresponded to a recently identified isoform of UDG1. This isoform (UDG1A) has a unique 44-amino acid N-terminal region and a C-terminal region that is identical to UDG1. To begin to study the signals required for nuclear targeting, the N-terminal regions of UDG1 and UDG1A were isolated and cloned into pEGFP-N2 to generate fusions with a redshifted variant of green fluorescent protein (GFP). When these constructs were transfected into NIH3T3 cells, UDG1/pEGFP was targeted to the mitochondria, and UDG1A/pEGFP was targeted to the nucleus. Further studies, using deletion mutants, demonstrate that the nuclear localization signal resides within the first 20 amino acids of UDG1A. To investigate the possibility that the heterogeneity observed on SDS-PAGE results from post-translational modification(s), the UDG/ pEGFP fusion constructs were transfected into NIH3T3 cells, and the cells were metabolically labeled with [ 32 P]orthophosphate. Results from these experiments show that UDG1A is a phosphoprotein. Subsequent phosphoamino acid analysis revealed that UDG1A is phosphorylated on both serine and threonine residues. As a final characterization, RNase protection assays were performed to examine expression of each of these isoforms. These studies demonstrate that UDG1A is expressed in a wide variety of cell types and that message levels are elevated in transformed cells.
The deamination of cytosine to uracil is a potentially mutagenic event. This damage must be recognized and repaired before replication in order to preserve the genomic integrity of a cell (1) . Uracil-DNA glycosylase (UDG) 1 catalyzes the first step in the base excision repair pathway to remove uracil from DNA (2) . The enzyme hydrolyzes the N-glycosyl bond between the uracil base and the deoxyribose sugar moiety. The resulting apyrimidinic site is then repaired by the sequential actions of an AP endonuclease, phosphodiesterase, DNA polymerase, and DNA ligase (3, 4) . Mol et al. (5) have recently determined the crystal structure of the highly conserved human uracil-DNA glycosylase (UDG1). These studies identified the active site groove and uracil-binding pocket and explain the selectivity for uracil over other pyrimidine bases in DNA.
Given the importance of this enzyme, it is not surprising that uracil-DNA glycosylases have been studied extensively in a variety of bacteria, viruses, and eukaryotic organisms (4) . Some of the most intriguing recent data suggest a role for uracil-DNA glycosylase in DNA replication as well as repair. For example, in vaccinia virus and cytomegalovirus, uracil-DNA glycosylase is required for DNA synthesis and viral replication (6 -8) . Additionally, the N-terminal region of the highly conserved human uracil-DNA glycosylase (UDG1) associates with replication protein A2 (9) . It has been suggested that this interaction may recruit UDG1 to the DNA replication-repair complex.
In humans, four putative uracil-DNA glycosylases have been identified. These include the following: 1) a 29,000 molecular weight protein that is highly conserved in nature (10); 2) a cyclin-like protein (UDG2) (11); 3) thymine-DNA glycosylase (12) ; and 4) a recently identified isoform of the highly conserved uracil-DNA glycosylase (UDG1A) (13) . At present an in vivo role for many of these proteins is unclear. For example, the cyclin-like UDG2 generates uracil-DNA glycosylase activity in vitro and specifically interacts with the uracil-DNA glycosylase inhibitor protein (11, 14) . However, we do not know how or when this (uracil-removing) activity is required by the cell. Similarly, thymine-DNA glycosylase can remove uracil from duplex G/U substrates in vitro (12) . Gallinari and Jiricny (12) postulate that this enzyme may function to remove uracil damage when the cell is at rest or is not proliferating. It has also been reported that partially purified preparations of the M r 36,000 subunit of glyceraldehyde-3-phosphate dehydrogenase contains uracil-DNA glycosylase activity (15) . However, results from our laboratory indicate that this may be due to UDG contamination of the glyceraldehyde-3-phosphate dehydrogen-ase preparations used in these studies (14) .
The best characterized human uracil-DNA glycosylase is the 29,000 molecular weight protein that we refer to as UDG1 (10) . UDG1 arises from proteolytic processing of a precursor during mitochondrial import and has been reported to play a role in mitochondrial DNA repair (14, 16) . Recently, a cDNA encoding a putative isoform of UDG1 was identified by Nilsen et al. (13) . We refer to this isoform as UDG1A. The UDG1A cDNA encodes a 313 amino acid protein with a unique 44-residue N terminus and appears to arise from alternate splicing. Constructs that express a fusion of UDG1A with green fluorescent protein show targeting to the nucleus (13) . However, because in vivo analyses of the native protein were not performed, questions remain as to the size and location of UDG1A within the cell.
To examine directly UDGs in human cell extracts, we have used the uracil-DNA glycosylase inhibitor protein (Ugi). In contrast to most organisms in nature, the PBS1 and PBS2 bacteriophages of Bacillus subtilis contain uracil in their genome (17) . To protect their DNA from host repair mechanisms, these phages synthesize an inhibitor that inactivates uracil-DNA glycosylase (18) . The uracil-DNA glycosylase inhibitor protein can specifically bind to and inactivate uracil-DNA glycosylase from a variety of organisms, including humans (19 -21) . We have recently conjugated Ugi to Sepharose beads and used this matrix to affinity purify uracil-DNA glycosylases from cellular extracts (14) . Results from these studies show that human cells contain multiple forms of this enzyme. One is the processed form (M r 29,000) of the highly conserved uracil-DNA glycosylase (UDG1) located in the mitochondria. The second is a group of at least three 35,000 -37,000 molecular weight proteins located in the nucleus. In the present study, we set out to identify and characterize the three apparent nuclear uracil-DNA glycosylases.
EXPERIMENTAL PROCEDURES
Affinity Purification of Nuclear Uracil-DNA Glycosylases-Cellular extracts were prepared from 1 ϫ 10 10 HeLa cells using a modification of the hypotonic shock protocol developed by Dignam et al. (22) . Briefly, cells were pelleted by centrifugation at 800 ϫ g for 15 min, washed once with ice-cold phosphate-buffered saline (PBS), and resuspended in 5 packed cell pellet volumes of buffer A (10 mM Hepes, pH 7.9; 1.5 mM MgCl 2 ; 10 mM KCl, and 0.5 mM DTT). After a 10 min incubation on ice, the cells were again collected by centrifugation (800 ϫ g/5 min) and resuspended in 2 cell pellet volumes of buffer A. The cells were then lysed with 10 strokes of a Kontes glass homogenizer using the B-type pestle. Complete lysis of the cells was monitored by phase contrast microscopy. Nuclei were pelleted by centrifugation (800 ϫ g/5 min) and washed twice with 5 volumes of buffer A. After the final wash, an aliquot of the nuclei were analyzed for mitochondrial contamination using a mitochondrion-selective dye (MitoTracker Green FM, Molecular Probes Inc., Eugene, OR). Nuclei were incubated in 20 nM MitoTracker for 30 min prior to analysis. Once it was established that the nuclei were free from significant mitochondrial contamination, they were resuspended in extraction buffer (50 mM Tris-HCl, pH 7.5; 250 mM NaCl; 0.1% Nonidet P-40, and 5 mM EDTA) and sonicated extensively. The extract was centrifuged at 10,000 ϫ g for 30 min to remove insoluble debris and then applied to the Ugi-Sepharose matrix. Preparation of the Ugi-Sepharose, incubation times, and wash conditions have been described previously (14) . Proteins were eluted by the addition of an equal volume of electrophoresis gel-loading buffer (50 mm Tris-HCl, pH 6.8; 100 mM dithiothreitol; 2% sodium dodecyl sulfide; 0.1% bromphenol blue, and 10% glycerol (v/v)). The samples were heated to 85°C and resolved by sodium dodecyl sulfate-12.6% polyacrylamide gel electrophoresis (SDS-PAGE). High range, protein molecular weight standards were purchased from Life Technologies, Inc., and used according to manufacturer's directions. These include the following: lysozyme, 14,300; ␤-lactoglobulin, 18,400; carbonic anhydrase, 29,000; ovalbumin, 45,000; bovine serum albumin, 68,000; phosphorylase b, 97,400; and myosin (H chain), 200,000.
Cell Culture-All cell lines were maintained in a humidified atmosphere of 5.5% CO 2 at 37°C. The cell lines were propagated as subconfluent monolayer cultures, and media were replenished 24 h prior to harvestings. HeLa S3 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% calf serum. Human fibroblast cell lines (34 Lu and 18 Co) and SV40-transformed placental trophoblasts were maintained in minimal Eagle's media containing 10% fetal bovine serum and supplemented with 2 mM glutamine. HT29 cells were grown in McCoy's 5A media containing 10% fetal bovine serum. NIH3T3 cells were maintained in DMEM supplemented with 10% calf serum.
Enzyme Renaturation and Activity Assays-Following SDS-PAGE, segments (1.5 ϫ 3 ϫ 1.5 mm) corresponding to each protein band were excised from the gel. The same size segments, located directly above and below the protein group, were also excised. Individual gel segments were crushed in 0.25 ml of elution buffer (0.1% SDS; 50 mM Tris-HCl, pH 7.9; 0.1 mM EDTA; 5 mM DTT; 200 mM NaCl, and 0.1 mg/ml bovine serum albumin), and the proteins were eluted for 1 h at room temperature. Protein renaturation was performed as described previously and yielded a 500-l final volume (14) . Activity assays were performed for 60 min using 5 l of renatured protein.
Uracil-DNA glycosylase assays were carried out as described by Muller and Caradonna (11) . All reactions were performed in a 100-l volume containing 50 mM Tris-HCl, pH 7.5, 2 mM dithiothreitol, 5 mM EDTA, 0.1 mg/ml bovine serum albumin, and 0.167 M [ 3 H]uracil containing calf thymus DNA. Reactions were incubated at 37°C for the times indicated and terminated by the addition of 25 l of salmon sperm DNA (25 g) and 25 l of 4 M perchloric acid. The samples were incubated on ice for 10 min and centrifuged. One hundred-microliter aliquots of supernatant were analyzed by liquid scintillation spectrometry. One unit of activity is defined as the amount of enzyme required to release 1 pmol of radiolabeled uracil per min at 37°C. All assays were performed in duplicate.
Protein Sequencing-The Ugi-purified proteins were separated by 12.6% SDS-PAGE and transferred to ProBlott membrane (Applied Biosystems) according to Towbin et al. (23) . The membrane was stained with Coomassie Brilliant Blue, and the bands were then individually excised from the membrane as directed by Proseq Inc. (Salem, MA). Protein sequence determinations were performed by Proseq Inc., using a selective o-phthalaldehyde blockade designed to minimize background and eliminate the purification of individual target peptides following cyanogen bromide digestion (24) . Briefly, the proteins (bound to polyvinylidene difluoride membrane) were digested with CNBr, and the resulting peptide mixture was subjected to several cycles of Edman degradation. o-Phthalaldehyde treatment was applied at cycles in which proline was the NH 2 terminus of the polypeptide of interest. This reagent covalently binds to and blocks all peptides with the exception of those containing a proline at their N terminus. In this way, individual peptides are able to be sequenced from the mixture. Amino acid sequencing and quantitation of Pth derivatives were performed using an Applied Biosystems model 494 Procise protein sequencing system.
Generation of UDG/pEGFP-N2 Fusion Constructs-Using sequence derived from an expressed sequence tag (EST) in GenBank TM , 2 a 5Ј primer was synthesized beginning at the UDG1A translational start (5Ј-ATGATCGGCCAGAAGACGCTCT-3Ј). This primer was used in conjunction with a 3Ј primer (5Ј-TCTCAAAGGCCACCCCTCAGCT-3Ј) to isolate the corresponding cDNA using an reverse transcriptase-PCR method. Reverse transcription of HeLa mRNA was carried out using avian myeloblastosis virus reverse transcriptase as described by the manufacturer (Promega Corp.). PCR was then performed for 30 cycles using an annealing temperature of 60°C. The DNA fragment was gel-purified, phosphorylated, end-filled, and ligated to SmaI-digested pGem3Z using established methods (25) . The resulting pGem3Z/ UDG1A construct was verified by DNA sequencing using the dideoxy chain termination method and Sequenase version 2.0 (U. S. Biochemical Corp.). The pGem3Z/UDG1A construct was then used as template DNA to generate the pEGFP-N2 fusion constructs.
The 86-amino acid N-terminal region of UDG1A (258 bp) was isolated using specific primers and PCR as described above. Similarly, primers were designed to isolate UDG1A fragments with 20-and 25-amino acid N-terminal deletions. For these constructs, an ATG codon was added to the 5Ј end of the upper primer. All of the DNA fragments were blunt end-ligated to SmaI-digested pEGFP-N2, and orientation was determined by restriction enzyme digestions. This vector produces an N-terminal fusion with a red-shifted variant of green fluorescent protein.
The resulting constructs are referred to as UDG1A/pEGFP, UDG1A-⌬20/pEGFP, and UDG1A-⌬25/pEGFP. The same approach was then used to isolate the 77-amino acid N-terminal region of UDG1 (231 bp Inc.) . Briefly, the cells were incubated at 37°C in a CO 2 incubator for 8 h in the presence of the DNA/Lipofectin mixture. This mixture was then removed and replaced with DMEM containing 10% calf serum. At 24 h post-transfection, the cells grown on coverslips were examined for green fluorescent protein (GFP) expression using a Ziess Axioskop fluorescent microscope. Alternatively, the cells grown in 10-cm 2 dishes were harvested at 24 h post-transfection for Western blot analysis. Cellular extracts were prepared in 1 ml of lysis buffer as described (26) . Western blotting was performed using anti-GFP polyclonal antibodies at a 1:2000 dilution as directed by the manufacturer (CLONTECH).
For metabolic labeling studies, NIH3T3 cells were seeded at 7 ϫ 10 5 cells/10-cm 2 dish and transfected as described above. The Lipofectin mixture was removed at 8 h post-transfection and replaced with 10 ml of DMEM (minus phosphate), 10% calf serum, and 125 Ci/ml of [ 32 P]orthophosphate (Amersham Pharmacia Biotech). Incubation at 37°C was continued for another 20 h at which time the cells were collected and washed twice in cold PBS. The cell pellets were resuspended in 1 ml of GFP lysis buffer (100 mM potassium phosphate, pH 7.8; 0.2% Triton X-100, and 1 mM DTT) and left on ice at 4°C for 15 h. The cell extracts were then centrifuged at 13,000 ϫ g for 10 min at 4°C to remove insoluble material. Polyclonal GFP antisera (5 g, CLON-TECH) were added to each of the supernatants, and the supernatants were incubated at 4°C for 2 h. Protein A-Sepharose (200 l of a 10% (w/v) suspension) was then added, and the mixture was incubated at 4°C for 1 h with constant agitation. The immune precipitate was collected by centrifugation and washed five times (1 ml each) with GFP lysis buffer. Following the last wash, samples were resuspended in 50 l of electrophoresis gel loading buffer and heated to 85°C for 10 min. Proteins recovered by immunoprecipitation were resolved by 12.6% SDS-PAGE, and the radiolabeled bands were visualized by autoradiography.
Phosphoamino Acid Analysis-To determine which amino acids of the UDG1A/pEGFP fusion protein were phosphorylated, [ 32 P]orthophosphate-labeled protein from NIH3T3-transfected cells were immunoprecipitated and fractionated by SDS-PAGE as described above. Fractionated proteins were electrophoretically transferred to Protoblot membranes (Applied Biosystems). The membranes were then exposed to x-ray film to localize the radiolabeled bands. The x-ray film was used as a template to identify and excise the corresponding radioactive bands from the membrane. Protein from these bands was hydrolyzed in 5.7 N HCl at 110°C for 1 h. The resulting amino acids were then analyzed by thin layer chromatography on SigmaCell type 100 cellulose plates in a solvent system consisting of propionic acid, 1 M NH 4 OH, 2-propanol (45:17.5:17.5) as described by Boyle et al. (27) . Phosphorylated Tyr, phosphorylated Thr, and phosphorylated Ser standards were included in the radioactive samples prior to chromatography. The dried chromatography plates were developed to visualize the phosphoamino acid standards according to established protocol (27) and then exposed to x-ray film to determine which amino acid residues contained phosphate groups.
Potato Acid Phosphatase Treatment of Ugi-purified Proteins-Total cell extracts were prepared from 1 ϫ 10 9 HeLa cells as described previously (14) . Briefly, the cells were resuspended in 10 packed cell pellet volumes of Nonidet P-40 buffer (50 mM Tris-HCl, pH 7.5, 250 mM NaCl, 0.1% Nonidet P-40, 50 mM NaF, and 5 mM EDTA) and incubated on ice for 1 h. Protease inhibitors were added to the buffer as indicated (14) . The cells were then disrupted by Dounce homogenization using a B-type pestle and centrifuged for 30 min at 10,000 ϫ g. The resulting supernatant was considered total cell extract and used for the affinity purification of uracil-DNA glycosylases.
Ugi-Sepharose (200 l of a 10% (w/v) solution) was mixed with the extracts (7.5 ϫ 10 7 cell eq in 2.5 ml) for 1 h at 4°C. The matrix was then washed extensively with Nonidet P-40 buffer, and phosphatase treatment was performed according to the procedure of Perez et al. (29) . Following the last wash, the affinity precipitates were resuspended in 200 l of phosphatase buffer (40 mM Pipes, pH 6.0; 1 mM dithiothreitol (DTT); 10 g/ml leupeptin, and 0.2 units of aprotinin) containing 20 g of potato acid phosphatase. The mixture was incubated for 30 min at 30°C. The precipitates were washed again, and proteins were eluted by adding an equal volume of electrophoresis gel-loading buffer and heating to 85°C. The samples were resolved by 12.6% SDS-PAGE and transferred to nitrocellulose (23) . Immunoblot analysis was performed using a new preparation of polyclonal antibodies that react with all forms of the highly conserved UDG (mitochondrial, UDG1, and nuclear UDG1A). These antibodies were raised against a soluble UDG1-GST fusion protein (glutathione S-transferase; pGEX, Amersham Pharmacia Biotech) using the procedure described previously (14) . This fusion protein corresponds to the full-length, non-processed UDG1 protein and thus contains regions shared by the UDG1 and UDG1A isoforms. The antibodies were used at a 1:500 dilution.
Ribonuclease Protection Assays-DNA segments corresponding to the unique N termini of UDG1 and UDG1A were isolated using PCR. A 104-bp UDG1 fragment was amplified using the following primers: upper (5Ј-ATGGGCGTCTTCTGCCTTGGGCGGTGGGGGT-3Ј) and lower (5Ј-TGCAAGTGGTCCCCGCAGAGGCGGCTCAAG-3Ј). A 129-bp UDG1A fragment was amplified using the following primers: upper (5Ј-ATGATCGGCCAGAAGACGCTCT-3Ј) and lower (5Ј-CCGCATCTC-CGCTTTCCTGAG-3Ј). These segments were ligated to SmaI digested pGem3Z and used to transcribe radiolabeled antisense RNA probes (25) . Total RNA was isolated from all cell lines using TRIzol reagent as directed (Life Technologies, Inc.). mRNA was then purified using the poly(A) tract mRNA isolation system (Promega Corp.) and quantitated. Following quantitation, each mRNA sample was divided in two, and ribonuclease protection assays were performed using the RPA II kit (Ambion Inc.) as described (29) . Each reaction contained 8 g of mRNA and 2 ϫ 10 5 cpm of specific probe. Control reactions were performed simultaneously using 5 g of yeast tRNA. Products were separated on a denaturing 6% polyacrylamide gel. The gel was dried and exposed to autoradiographic film for 24 -48 h.
RESULTS
Purification of Uracil-DNA Glycosylases from HeLa Cell Nuclei-As described earlier, we have used the uracil-DNA glycosylase inhibitor (Ugi) to affinity purify uracil-DNA glycosylases from HeLa cell extracts (14) . This method routinely yields at least three bands in the 35,000 -37,000 molecular weight range and a single 29,000 molecular weight band. We have shown that the 35,000 -37,000 molecular weight proteins are located in the nucleus, and the 29,000 molecular weight protein resides in the mitochondria. In the present study, we set out to identify and characterize the three apparent nuclear uracil-DNA glycosylases. To accomplish this, nuclear extracts were prepared from HeLa cells as described under "Experimental Procedures." Because 1 ϫ 10 10 cells were required to obtain protein quantities sufficient for microsequencing, two approaches were used to assess the purity of the isolated nuclei. First, the complete lysis of cells was monitored by phase contrast microscopy. Second, after the final wash, an aliquot of the nuclei was analyzed for mitochondrial contamination using a mitochondrion-selective dye (MitoTracker Green FM, Molecular Probes Inc., Eugene OR) (data not shown). This probe fluoresces only when it accumulates in the mitochondrial lipid environment and is retained there upon permeabilization. Results from these analyses showed that the extracts were free of unlysed cells and detectable mitochondrial contamination.
The nuclear extracts were then applied to a Ugi-affinity matrix and washed extensively. Uracil-DNA glycosylases were eluted as described under "Experimental Procedures." To evaluate the yield and purity of this method, an aliquot of the Ugi-purified proteins was analyzed by 12.6% SDS-PAGE and stained with Coomassie Blue. Results from this purification are presented in Fig. 1A . Three distinct bands are visible (labeled 1-3), ranging in apparent molecular weight from 35,000 to 37,000. Band 3, the fastest migrating of the three, is the most abundant protein species as judged by Coomassie staining. Note that there are no detectable bands in the 29,000 molecular weight range. This demonstrates the absence of mitochondrial uracil-DNA glycosylases and further establishes the purity of the nuclear extracts.
Each protein band was excised from the gel in 6.75-mm 3 sections, along with the same size region directly above and below the protein group. The proteins were eluted from each gel fragment and renatured, and 5-l aliquots were assayed for uracil-DNA glycosylase activity. Fig. 1B is a graphic representation of the uracil-DNA glycosylase activity generated from each band upon protein renaturation. Bands 1-3 generated 0.9, 2.5, and 0.8 units of activity, respectively. In contrast, no activity is detected in the region directly above or below this group of proteins. It is of interest to note that, although band 3 appears to be the most abundant protein species, it generates the lowest levels of uracil-DNA glycosylase activity. This discrepancy may be attributed to the variability associated with protein renaturation efficiencies. Alternatively, the band intensities, as judged by Coomassie staining, may not accurately reflect protein quantities. 3 The remainder of the Ugi-purified proteins were then prepared for direct protein microsequencing. The proteins were fractionated on a 12.6% polyacrylamide gel containing SDS, transferred to Problott membrane, and stained with Coomassie Blue. The three 35,000 -37,000 molecular weight bands (bands 1-3) were then excised from the membrane and sent to ProSeq Inc. for N-terminal sequencing.
Protein Sequence Analysis: Nuclear Uracil-DNA Glycosylase Is a Non-processed 36,000 M r Protein-The initial sequencing efforts revealed that all of the proteins were N-terminally blocked. To overcome this obstacle, each band was individually digested with cyanogen bromide which cleaves the protein after methionine residues. The resulting peptides were subjected to Edman degradation using a selective o-phthalaldehyde blockade that is designed to minimize background and eliminate the purification of individual target peptides following cyanogen bromide digestion (24) . It is important to note that no contaminating (non-UDG) peptide sequences were identified at any point in this analysis. Amino acid sequences derived from each peptide are presented in Table I . Band 3 was analyzed first because it was the most abundant protein species as judged by Coomassie staining. One-third of this sample was used for analysis, and the phenylthiohydantoin (Pth) amino acid yields were between 1.2 and 0.25 pmol. Three detectable peptides were generated by cyanogen bromide digestion and are designated M 1 , M 115 , and M 140 . Sequence derived from peptide M 1 corresponds to the unique region of a putative uracil-DNA glycosylase isoform (UDG1A) recently reported by Nilsen et al. (13) . UDG1A is an alternatively spliced form of the highly conserved uracil-DNA glycosylase that has a unique 44 amino acid N terminus. Sequences derived from the peptides M 115 and M 140 also correspond to sequences within UDG1A. The designation given to each peptide denotes the position of the cleaved methionines within UDG1A.
When Bands 1 and 2 were digested with cyanogen bromide and analyzed by Edman degradation, the same sequences were obtained, although four peptide fragments were generated. In addition to peptides 1 . Purification of nuclear uracil-DNA glycosylases. A, Ugi affinity chromatography. HeLa cell nuclear extracts were prepared and incubated with Ugi-Sepharose as described under "Experimental Procedures." The matrix was washed extensively and resuspended in an equal volume of SDS-PAGE loading buffer. UDG proteins were eluted by heating the sample to 85°C, separated by 12.6% SDS-PAGE, and stained with Coomassie Blue. High range molecular weight protein standards (Life Technologies, Inc.) were also applied to the gel and are denoted on the right. B, renaturation of uracil-DNA glycosylase activity. Segments corresponding to the three bands were individually excised from the gel along with the region directly above and below the protein group. Proteins were eluted from each 6.75-mm 3 gel slice and renatured as described under "Experimental Procedures." Uracil-DNA glycosylase assays were then performed in duplicate for 60 min using 5 l of renatured protein. 
Parentheses indicate weak or ambiguous identification. a Sequence terminated at 15 cycles; no new information apparent.
amino acid yields for bands 1 and 2 were also between 0.97 and 0.2 pmol; however, in each case, the entire sample was analyzed. These results are consistent with protein levels for bands 1-3 as judged by Coomassie staining (Fig. 1A) . Collectively, these studies indicate that the three Ugi-purified proteins have identical amino acid sequence and are encoded by a novel uracil-DNA glycosylase cDNA recently identified by Nilsen et al. (13) . In addition, these results demonstrate that the nuclear uracil-DNA glycosylase is an M r 36,000 protein that is not processed to a lower molecular weight form. The N-terminal Region Targets UDG1A to the Nucleus-To begin to study the signals required for nuclear targeting, a 939-bp UDG1A cDNA was isolated as described under "Experimental Procedures." This cDNA encodes a protein that is 9 amino acids larger than UDG1 and has a unique 44-amino acid N terminus. As depicted in Fig. 2A , the two isoforms are identical from amino acid 45 (amino acid 36 in UDG1) to the end of the open reading frame. Note that UDG1 contains a 77-amino acid targeting sequence that is cleaved during mitochondrial import to produce a mature protein with M r of 29,000 (14, 16) . UDG1A shares 42 of the 77 residues associated with this signal sequence. However, there is also a putative nuclear localization signal (NLS) located in the unique region of UDG1A, and it is underlined in Fig. 2A (13) . This structural organization suggests that signals in the divergent N-terminal regions of UDG1 and UDG1A direct these proteins to their distinct subcellular locations.
A 231-bp fragment encoding the mitochondrial targeting region of UDG1 (amino acids 1-77) was isolated by PCR and ligated to the pEGFP-N2 vector to create UDG1/pEGFP. Similarly a 264-bp fragment encoding the first 86 amino acids of UDG1A was isolated by PCR and ligated to pEGFP-N2 to create UDG1A/pEGFP. This UDG1A fragment includes the unique 44-amino acid N-terminal region as well as 42 residues that are shared by both isoforms. These constructs produce an N-terminal fusion with a variant of green fluorescent protein that fluoresces at an excitation wavelength of 488 nm. In addition, a 20-amino acid N-terminal deletion mutant of UDG1A, lacking the putative nuclear localization signal was constructed (UDG1A-⌬20/pEGFP). These constructs were transfected into NIH3T3 cells as described under "Experimental Procedures." At twenty four hours post-transfection, the cells were harvested, and extracts were analyzed by immunoblotting with GFP polyclonal antibodies. Data from these experiments are presented in Fig. 2B . The wild type pEGFP vector produces a single M r 27,000 protein that is readily detected by the GFP antibodies. UDG1/pEGFP produces two proteins: one at an approximate molecular weight of 32,000 and a second at 27,000. However, the predicted size for the full-length UDG1/ pEGFP fusion protein is 35,000 (27,000 from GFP ϩ 8,500 from UDG1). These truncated products, therefore, are likely to represent proteolytically processed forms of UDG1. When the UDG1A/pEGFP construct was analyzed, a major band is identified at M r 36,500 that corresponds to the predicted size for a non-processed protein (27,000 from EGFP ϩ 9,500 from UDG1A). Two minor bands can also be detected at approximate molecular weights of 29,000 and 27,000 that may represent spurious cleavage products or result from proteolytic degrada-
FIG. 2. Structural organization and Western analysis of UDG/pEGFP constructs.
A, schematic representation of the UDG N-terminal regions that were cloned into pEGFP. The N-terminal region of UDG1 (amino acids 1-77) is composed of 35 unique residues and 42 residues that are shared with UDG1A. This region was cloned into pEGFP to create UDG1/pEGFP. The vertical arrow indicates the site of mitochondrial processing. The N-terminal region of UDG1A is composed of 44 unique residues and 42 residues that are shared with UDG1. This region was cloned into pEGFP to create UDG1A/pEGFP. The putative nuclear localization signal in UDG1A is underlined. UDG1A-⌬20 is an N-terminal deletion mutant of UDG1A that lacks the first 20 amino acids including the putative NLS. UDG1A-⌬25 is an N-terminal deletion mutant of UDG1A that lacks the first 25 amino acids. Sequence common to both isoforms is denoted by the gray speckled boxes. B, Western analysis of transfected cell lines. The UDG/pEGFP constructs were transfected into NIH3T3 cells as described under "Experimental Procedures." Cells were harvested at 24 h post-transfection, and extracts were prepared. 40 g of extract were applied to each lane, and the samples were resolved by 12.6% SDS-PAGE. The proteins were then transferred to nitrocellulose and analyzed by Western blotting with polyclonal GFP antibody (CLONTECH). Lanes are labeled with the construct name that was used for each transfection. High range molecular weight protein standards (Life Technologies, Inc.) are indicated on the right.
tion. Finally, the UDG1A-⌬20/pEGFP construct (lacking the putative NLS) generates 2 bands that migrate slightly faster than wild type UDG1A/pEGFP. Although we cannot explain the appearance of 2 bands, both correspond to the predicted size for a non-processed protein.
To examine the intracellular location of these proteins, NIH3T3 cells were seeded on coverslips and transfected with the UDG/pEGFP constructs. Twenty four hours following the transfections, the coverslips were examined using a Ziess Axioskop equipped for fluorescence microscopy. Fig. 3A shows that expression of pEGFP produces a diffuse cytoplasmic fluorescence that encompasses the entire cell. Expression of UDG1/ pEGFP produces a particulate fluorescence pattern that is excluded from the nucleus (Fig. 3B) . This pattern is identical to that produced when cells are stained with a mitochondrial marker (MitoTracker Green FM, Molecular Probes Inc., Eugene OR, data not shown). When cells were transfected with UDG1A/pEGFP intense nuclear staining is observed (Fig. 3C) . With the exception of the crescent-shaped cell located in the lower right-hand corner, cells transfected with UDG1A/pEGFP reveal exclusive nuclear staining. We attribute the cytoplasmic fluorescence seen in this particular cell to overexpression of the UDG1A/pEGFP protein. Nuclear targeting is eliminated when the first 20 amino acids of UDG1A are removed (UDG1A-⌬20, Fig. 3D ). Cells transfected with UDG1A-⌬20/pEGFP exhibit diffuse cytoplasmic staining, similar to that observed for pEGFP. Collectively, the immunoblot analysis, immunolocalization studies, and our previous results (14) show that the N-terminal region of UDG1 targets the protein to the mitochondria upon which it is processed to a lower molecular weight mature form. In addition, the data demonstrate that nuclear targeting of UDG1A is mediated by signals located within the first 20 amino acids and does not involve a processing event. When the NLS is removed, the protein remains in the cytoplasm.
UDG1A Is a Phosphoprotein-Because each of the three Ugipurified proteins generated identical peptide sequences, we proposed that the heterogeneity observed on SDS-PAGE may result from post-translational modification. To investigate the possibility that UDG1A is phosphorylated, another series of transfections was performed using the UDG/pEGFP fusion constructs. For these studies, [ 32 P]orthophosphate was added to the cells at 8 h post-transfection, and incubation at 37°C continued for an additional 20 h. Following the transfections, UDG/pEGFP proteins were immunoprecipitated using polyclonal GFP antibodies and separated by SDS-PAGE. Fig. 4A presents the results of these studies. There are no significant phosphorylated proteins recovered from cells transfected with pEGFP or UDG1/pEGFP. However, when cells are transfected with UDG1A/pEGFP, a 32 P-labeled protein of M r 36,000 is specifically immunoprecipitated by the polyclonal GFP antibodies. To investigate further the nature of this phosphorylation event, two N-terminal deletion mutants were analyzed, UDG1A-⌬20/pEGFP and UDG1A-⌬25/pEGFP. As shown in Fig. 2A , the ⌬20 deletion removes three of the four serine residues that flank the NLS and may represent putative targets of proline-directed phosphorylation. The ⌬25 deletion removes the fourth serine residue located in this cluster. When these mutants were transfected into NIH3T3 cells and ana- 32 P]orthophosphate as described under "Experimental Procedures." Cells were harvested at 24 h post-transfection, and extracts were prepared in 1 ml of GFP lysis buffer. The UDG/pEGFP proteins were then immunoprecipitated from these samples using polyclonal GFP antibodies. Following the last wash, each sample was resuspended in 50 l of electrophoresis gel loading buffer, heated, and resolved by 12.6% SDS-PAGE. The gel was dried and exposed to autoradiographic film (Kodak, XAR) for 24 h. Lanes are labeled with the construct name that was used for each transfection. High range molecular weight protein standards (Life Technologies, Inc.) are indicated on the right. B, phosphoamino acid analysis. In a separate experiment, NIH3T3 cells were transfected, labeled with [
32 P]orthophosphate, and the UDG/pEGFP proteins were immunoprecipitated as described above. The radiolabeled proteins were then excised from the gel and hydrolyzed. The resulting amino acids were separated by thin layer chromatography. Lanes are labeled with the construct name that was used for each transfection. Positions of the phosphorylated tyrosine, threonine, and serine standards are noted on the left. lyzed as described above, both proteins remain phosphorylated (Fig. 4A, lane UDG1A-⌬20 and UDG1A-⌬25) .
To determine which amino acids in UDG1A are phosphorylated, the three constructs (UDG1A/pEGFP, UDG1A-⌬20/ pEGFP, and UDG1A-⌬25/pEGFP) were individually transfected into NIH3T3 cells in the presence of [ 32 P]orthophosphate. Following the transfections, 32 P-labeled proteins were immunoprecipitated and fractionated by SDS-PAGE. The radiolabeled proteins were then excised from the gel and hydrolyzed, and the resulting amino acids were separated by thin layer chromatography. Phosphorylated tyrosine, threonine, and serine standards were included in the radioactive samples prior to chromatography and served as standards. Fig. 4B shows that wild type UDG1A/pEGFP is phosphorylated on both serine and threonine residues. Because it was difficult to separate phosphothreonine and phosphotyrosine using this solvent system, the absence of phosphotyrosine was confirmed using anti-phosphotyrosine antibodies. These antibodies did not bind to UDG1A/EGFP in Western blot or immunoprecipitation analysis (data not shown). Interestingly, the same pattern of phosphorylation is evident for both UDG1A-⌬20 and UDG1A-⌬25 (Fig. 4B) . Since there is only one threonine and only one serine residue remaining in the unique region of the UDG1A-⌬25 fragment, threonine 31 and serine 40 are likely targets of phosphorylation (see Fig. 2A ). However, it is also possible that residues located in the common region (residues 45-86) are also phosphorylated. These residues may not be accessible in UDG1 or are removed during mitochondrial processing.
To test more directly the hypothesis that the three Ugipurified bands result from differential phosphorylation events in vivo, we incubated Ugi affinity precipitates in the presence of potato acid phosphatase. For this experiment, uracil-DNA glycosylases were Ugi affinity purified from total cell extracts as described under "Experimental Procedures." Total cell extracts were chosen because both the nuclear and mitochondrial forms of UDG1 are isolated using this method (14) . Mitochondrial UDG1 (M r ϭ 29,000) is not phosphorylated and therefore serves as an internal control. Following phosphatase treatment, the samples were separated by SDS-PAGE and analyzed by immunoblotting with newly generated polyclonal antibodies that react with all forms of the highly conserved UDG (mitochondrial, UDG1, and nuclear UDG1A). Results from this experiment are presented in Fig. 5 . In the absence of phosphatase, three nuclear 35,000 -37,000 molecular weight bands and a single mitochondrial M r 29,000 band are apparent (lane Ϫ). In the presence of potato acid phosphatase, the three M r 35,000 -37,000 bands are shifted to a single band, and the position of the mitochondrial M r 29,000 band is not changed (lane ϩ). These results demonstrate that the nuclear UDG1A is phosphorylated on multiple sites in vivo to produce the heterogeneous pattern that is observed following SDS-PAGE.
Expression Patterns of UDG1 and UDG1A-To begin to characterize the expression of UDG1A, mRNA was isolated from a variety of cell types and used to perform RNase protection analysis. Specifically, we were interested in examining message levels of UDG1A relative to UDG1 in these cell types. To accomplish this, isoform-specific probes were generated corresponding to a 104-bp unique region of UDG1 and a 129-bp unique region of UDG1A. As described under "Experimental Procedures," each mRNA sample was quantitated and divided immediately prior to hybridization. It should also be noted that all cell lines were actively dividing at the time of mRNA isolation. Results from these studies are presented in Fig. 6 . The left panel shows UDG1 and UDG1A message levels in three transformed cell lines as follows: HeLa, HT29 (colon cancer), and a placental cell line transformed with SV40. It is evident that both UDG1 and UDG1A are expressed in all of the transformed cell lines. In each case, levels of UDG1A message (lanes 1A) appear greater than or equal to levels of UDG1 message (lanes 1). Overexpression of UDG1A relative to UDG1 is most apparent in the HeLa and placental cells.
The same analysis was then performed on non-transformed human fibroblasts (Fig. 6, lanes 34 Lu and 18 Co). Again, expression of both UDG1 and UDG1A is evident in both cell types. However, UDG1A message levels are markedly reduced relative to levels of UDG1. Collectively, these studies demonstrate that UDG1A is expressed in a wide variety of cell types and that its relative expression level is elevated in the transformed cell lines surveyed.
DISCUSSION
In this report we set out to characterize three putative nuclear uracil-DNA glycosylase proteins that were previously identified in our laboratory using a novel affinity purification method (14) . To accomplish this, we performed a large scale Ugi purification using nuclear extracts derived from 1 ϫ 10 10 HeLa cells. The resulting proteins were individually digested with cyanogen bromide, and the peptide fragments were microsequenced. Interestingly, the sequence derived from each of the three bands corresponded to a putative isoform of UDG1 that we refer to as UDG1A. A cDNA encoding UDG1A was recently identified by Nilsen et al. (13) . These investigators showed that it arises through alternate splicing and encodes a 313-amino FIG. 5 . Potato acid phosphatase treatment of Ugi-purified glycosylases. Uracil-DNA glycosylases were affinity purified from total HeLa cell extracts (7.5 ϫ 10 7 cell eq) using Ugi-Sepharose as described. After washing, the affinity precipitates were resuspended in 200 l of phosphatase buffer and incubated for 10 min at 30°C in the absence (lane Ϫ) or presence (lane ϩ) of potato acid phosphatase (10 g). The samples were separated on a SDS-12.6% acrylamide gel and transferred to nitrocellulose. Immunoblot analysis was then performed using polyclonal antibodies (1:500 dilution) that react with all forms of the highly conserved UDG (mitochondrial, UDG1, and nuclear UDG1A). Protein molecular weight standards are denoted on the right.
FIG. 6.
Ribonuclease protection analysis of UDG1 and UDG1A. mRNA was isolated from cycling HeLa, HT29, placental, 34 Lu, and 18 Co cells. RNase protection was performed using a 104-bp probe corresponding to the 5Ј region of UDG1 or a 129-bp probe corresponding to UDG1A. 8 g of mRNA was used in each reaction. Lanes marked 1 signify that UDG1 probe was added to the reaction. Lanes marked 1A signify that UDG1A probe was added to the reaction. Cell types from which the mRNA was derived are denoted above each lane. Control reactions contained 5 g of yeast tRNA and are marked Control. mRNA sizes are indicated in bp on the right.
acid protein that has a unique 44-residue N terminus. However, because their studies did not include an in vivo analysis of UDG1A, questions remained as to its size and location in the cell. Data presented in this paper therefore confirm and extend the recent work of Nilsen et al. (13) .
Admittedly, the results of this analysis were surprising. In a previous study we showed that our original polyclonal antibodies generated against UDG1 did not recognize the nuclear Ugi-purified proteins (14) . It is possible that these antibodies react with epitopes located in the N-terminal region of UDG1. These epitopes may be absent, altered, or masked in UDG1A, resulting in a decreased affinity for the UDG1A isoform. This explanation is consistent with our previous results from cycloheximide-treated HeLa cell extracts, as well as cell-staining experiments that showed a particulate cytoplasmic staining (14) . It is also important to note that the current protein sequence analysis did not identify UDG1 or the cyclin-like UDG2. Although it is possible that these proteins were not recovered in appreciable levels to be detected, these results show that UDG1A is the primary source of uracil-DNA glycosylase activity in HeLa cell nuclei. Although UDG2 generates uracil-DNA glycosylase activity in vitro and binds to Ugi-Sepharose, it is not a significant source of activity in this cell type.
To investigate the signals that mediate subcellular localization of both isoforms, we cloned the N-terminal region of UDG1 (77 amino acids) and UDG1A (86 amino acids) into pEGFP-N2. This vector creates an N-terminal fusion with a variant of green fluorescent protein and was chosen because specific antibodies are not required for in vivo detection. Our rationale for using NIH3T3 cells is based on the recent finding that the UDG exon organization and splice sites in mouse are identical to that in humans (13) . This and earlier work by Domena et al. (30) showing distinct nuclear and mitochondrial forms of UDG in rat liver indicate that human and NIH3T3 cells will have similar mechanisms for processing.
Recall that the 77-amino acid N-terminal region of UDG1 is a mitochondrial targeting peptide that is cleaved upon transport into the mitochondria (14, 16) . Similarly, when we transfected NIH3T3 cells with UDG1/pEGFP, a punctate fluorescent pattern was observed that is indicative of mitochondrial localization (Fig. 3B) . When the UDG1/pEGFP-transfected cell lines were analyzed by immunoblotting with GFP polyclonal antibody, two proteins resulted: one with an M r of 27,000 and a second at 32,000 ( Fig. 2A) . The 27,000 molecular weight band is expected to result from the complete removal of the UDG1 mitochondrial presequence. However, the 32,000 molecular weight band does not correspond to the predicted molecular weight of either the full-length fusion protein or the processed protein. Several explanations may account for this. First, mitochondrial processing of matrix proteins is a two-step event, during which an intermediate partially processed protein is generated (31) . It is possible that this is a rate-limiting step and buildup of an intermediate 32,000 molecular weight band would thus result. This idea is supported experimentally by Domena et al. (30) , who showed that in rodent cells there are two forms of mitochondrial uracil-DNA glycosylase that also differ in molecular weight by 5,000. A second possibility is that the 32,000 molecular weight band may result from anomalous processing of a human protein in rodent cells. Finally, the 32,000 molecular weight band may be attributed to anomalous migration of the full length, unprocessed form.
As mentioned earlier, the 86-bp N-terminal region of UDG1A shares 42 residues with the UDG1 amphipathic mitochondrial presequence. Interestingly, this region includes two highly conserved arginine residues at position Ϫ2 and Ϫ10 (relative to the proteolytic cleavage site) that are essential for proteolytic processing (32) . There is also a putative nuclear localization signal composed of basic amino acids located at residues 17-20 ( Fig.  2A) . It was therefore of interest to examine the interplay of signals located within this region. When UDG1A/pEGFP was transfected into NIH3T3 cells, nuclear localization was apparent (Fig. 3C ). These results demonstrate that the putative NLS overrides signals for mitochondrial targeting and processing. Western analysis using GFP polyclonal antibodies revealed a single M r 36,000 protein and demonstrate that there is no detectable proteolytic processing of nuclear UDG1A (Fig. 2B) .
Nilsen et al. (13) have also identified a putative NLS in the catalytic region that is shared by UDG1 and UDG1A. This is also a basic sequence (RKRHH) and is located at residues 267-272 in UDG1A. These investigators propose that both NLSs are required for nuclear transport. However, our studies demonstrate that a single NLS, located in the N terminus, is sufficient to direct nuclear targeting. To investigate further the role of the N-terminal NLS, a UDG1A deletion mutant was created lacking the first 20 amino acids (UDG1A-⌬20). When this construct was transfected into NIH3T3 cells, nuclear localization was eliminated, and a diffuse fluorescence was observed (Fig. 3D) . These results show that the first 20 residues of UDG1A are essential for nuclear targeting. In addition, the diffuse fluorescence pattern suggests that UDG1-⌬20 is distributed in the cytoplasm and does not "default" to the mitochondria as previously suggested by Nilsen et al. (13) .
The N-terminal region of UDG1A is rich in serine residues and contains motifs similar to those found in targets of prolinedirected kinases such as the mitogen-activated protein kinases and cyclin-dependent kinases (33, 34) . This observation, along with the multiple bands identified following Ugi purification, suggested that UDG1A may be a phosphoprotein. To investigate this possibility, transfection experiments were performed using the UDG1/pEGFP and UDG1A/pEGFP constructs in the presence of [ 32 P]orthophosphate. Results from these experiments and subsequent phosphoamino acid analysis show that UDG1A is phosphorylated on serine and threonine residues (Fig. 5, A and B) , whereas UDG1 is not phosphorylated.
When the UDG1-⌬20 and UDG1-⌬25 constructs were examined, phosphorylation of serine and threonine residues was still evident (Fig. 4B) . These deletion mutants removed 3 (UDG1A-⌬20) and 4 (UDG1A-⌬25) serine residues located adjacent to the NLS. An additional serine and threonine residue remain in the unique region of UDG1A and therefore represent likely targets of phosphorylation. However, these results do not rule out the possibility that UDG1A is also phosphorylated on additional residues located upstream of amino acid 25 (i.e. residues associated with the NLS). In fact, the multiple bands seen following SDS-PAGE suggest a heterogeneous phosphorylation pattern in vivo.
This hypothesis was confirmed by incubating Ugi affinity precipitates in the presence and absence of potato acid phosphatase (Fig. 5) . These studies were performed using total HeLa cell extract such that the non-phosphorylated UDG1 (M r ϭ 29,000) would serve as an internal control. When treated with phosphatase, the three 35,000 -37,000 molecular weight bands were shifted to a single band. These studies corroborate the earlier protein sequencing data and demonstrate that the multiple bands are a direct result of differential phosphorylation events. Although the in vivo consequences of UDG1A phosphorylation are unknown at this time, it is intriguing to speculate that these events may modulate enzymatic activity or protein-protein associations.
In the final set of experiments, we used RNase protection assays to study expression of UDG1A relative to UDG1 in various cell types. Results obtained from non-transformed cell lines demonstrate that levels of UDG1A mRNA are significantly lower than levels of UDG1 mRNA. Conversely, in transformed cell lines (most notably, HeLa and placental trophoblasts, Fig. 6 ), UDG1A message levels are elevated relative to UDG1 message. These results suggest that UDG1A may be expressed in a proliferation-dependent manner since the transformed lines have much higher rates of proliferation than the non-transformed fibroblasts used in this study. 4 Close examination of the UDG1A-protected fragments derived from the transformed cells reveals two closely migrating bands. At this time, we do not know if this represents yet another UDG isoform or is simply an artifact of the system. We suspect that it may be an RNase-sensitive site because the protein sequence data did not identify any additional unique sequences.
The differential expression and genomic organization of UDG1 and UDG1A suggest that regulation is carried out through the use of alternate promoters. Haug et al. (35) have demonstrated that the 516-bp region immediately upstream of the first UDG1 exon can drive transcription in vitro. This region is rich in SP-1-binding sites, does not contain TATA sequences, and is reminiscent of promoters that drive expression of housekeeping genes. Similarly, Nilsen et al. (13) have shown that the region immediately upstream of the unique UDG1A exon can support transcription of a luciferase gene construct. This region contains putative binding sites for many regulatory proteins including Myb, AP2, Fos, and p53. It is therefore probable that UDG1 and UDG1A message levels may depend solely upon differential promoter activation. This type of regulatory mechanism has been well characterized in many genes (36) .
In summary, this report describes the identification and characterization of a novel uracil-DNA glycosylase, UDG1A, from HeLa cells. Data presented in this paper confirm and extend the recent work of Nilsen et al. (13) . We demonstrate that an NLS in the N-terminal region of UDG1A directs this protein to the nucleus and that removal of this signal obliterates targeting. We show that the heterogeneity observed following SDS-PAGE is the result of multiple phosphorylations on serine and threonine residues. In addition, our findings illustrate that UDG1A is differentially expressed in a variety of cell types, and we have discussed a possible mechanism for this regulation.
